Who Paid My Doc
Juhi Kumar
Pediatric Nephrology Pittsburgh, PA Medical Doctor
NPI 1710115282 CMS profile 411914
4401 Penn Avenue, Pittsburgh, PA 15224
General payments
$259
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$2,079
Through program year 2024, Juhi Kumar of Pittsburgh, PA is reported in the CMS Open Payments database as having received $259 across 3 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $2,079 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 51st percentile of Pediatric Nephrology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
2 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2024 | General | $33 | 1 | |
| 2023 | General | $227 | 2 |
Beside peers
- Juhi Kumar
- Pediatric Nephrology median
- Middle half of Pediatric Nephrology
- National median
In program year 2025, general payments to Juhi Kumar were reported at $0. Among 327 Pediatric Nephrology profiles paid that year, the median was $131 and the middle half received between $47 and $474.
Show as a table
| Year | Juhi Kumar | Pediatric Nephrology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $123 | $48–$353 | $163 |
| 2020 | $0 | $146 | $24–$2,251 | $114 |
| 2021 | $0 | $138 | $26–$1,371 | $132 |
| 2022 | $0 | $93 | $25–$427 | $149 |
| 2023 | $227 | $105 | $30–$375 | $160 |
| 2024 | $33 | $123 | $40–$481 | $164 |
| 2025 | $0 | $131 | $47–$474 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 2 drugsPart D claims
50
Drug cost
$292
Branded share of claims
66%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | Brand | 33 | $242 | |
| Carvedilol | Generic | 17 | $49 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 9,003 Part D prescribers listed as Nephrology; they describe a distribution and say nothing about conduct.
Records
3 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Pediatric Nephrology in Pennsylvania
German Lozano Guzman
Pediatric Nephrology · Philadelphia, PA
Brenda Cooperstone
Pediatric Nephrology · Bryn Mawr, PA
Christine Sethna
Pediatric Nephrology · Philadelphia, PA
Sandra Amaral
Pediatric Nephrology · Philadelphia, PA
Susan Furth
Pediatric Nephrology · Philadelphia, PA
Carlton Bates
Pediatric Nephrology · Pittsburgh, PA
Related records
Pediatric Nephrology in Pennsylvania
Practitioners in the same specialty and state, ranked by reported value.
All Pediatric Nephrology
Everyone recorded under this specialty, nationwide.
Doctors in Pennsylvania
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.